Updated Estimates and Mapping for Prevalence of Chagas Disease Among Adults, United States

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2022 Jun 22

PMID 35731040

Authors

Amanda Irish

Jeffrey D Whitman

Eva H Clark

Rachel Marcus

Caryn Bern

Affiliations

Soon will be listed here.

Abstract

We combined American Community Survey data with age-specific Trypanosoma cruzi prevalence derived from US surveys and World Health Organization reports to yield estimates of Chagas disease in the United States, which we mapped at the local level. In addition, we used blood donor data to estimate the relative prevalence of autochthonous T. cruzi infection. Our estimates indicate that 288,000 infected persons, including 57,000 Chagas cardiomyopathy patients and 43,000 infected reproductive-age women, currently live in the United States; 22-108 congenital infections occur annually. We estimated ≈10,000 prevalent cases of locally acquired T. cruzi infection. Mapping shows marked geographic heterogeneity of T. cruzi prevalence and illness. Reliable demographic and geographic data are key to guiding prevention and management of Chagas disease. Population-based surveys in high prevalence areas could improve the evidence base for future estimates. Knowledge of the demographics and geographic distribution of affected persons may aid practitioners in recognizing Chagas disease.

Citing Articles

Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.

Altcheh J, Grossmann U, Stass H, Springsklee M, Garcia-Bournissen F PLoS Negl Trop Dis. 2025; 19(2):e0012849.

PMID: 39999088 PMC: 11856279. DOI: 10.1371/journal.pntd.0012849.

A Trans-Sialidase Peptide Demonstrates High Serological Prevalence Among Infected Populations Across Endemic Regions of Latin America.

Kortbawi H, Marczak R, Rajan J, Bulaong N, Pak J, Wu W medRxiv. 2025; .

PMID: 39974016 PMC: 11838992. DOI: 10.1101/2025.01.22.25320967.

Epidemiology of Chagas Disease in the United States of America: A Short Review and Some Comments.

Klotz S Pathogens. 2025; 14(1).

PMID: 39860985 PMC: 11768169. DOI: 10.3390/pathogens14010024.

Chagas disease treatment efficacy markers: experiences from a Phase III study with nifurtimox in children.

Grossmann U, Rodriguez M Front Parasitol. 2025; 2():1229467.

PMID: 39816835 PMC: 11732161. DOI: 10.3389/fpara.2023.1229467.

Bridging the critical gap between infectious disease blood donation screening and connection to healthcare services: the American Chagas disease example.

Lynn M, Parker M, Stramer S, Townsend R, Nolan M J Public Health Policy. 2024; 46(1):168-179.

PMID: 39695217 PMC: 11893461. DOI: 10.1057/s41271-024-00539-5.

References

Manne-Goehler J, Umeh C, Montgomery S, Wirtz V . Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016; 10(11):e0005033. PMC: 5098725. DOI: 10.1371/journal.pntd.0005033. View

Cantey P, Stramer S, Townsend R, Kamel H, Ofafa K, Todd C . The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012; 52(9):1922-30. DOI: 10.1111/j.1537-2995.2012.03581.x. View

Forsyth C, Manne-Goehler J, Bern C, Whitman J, Hochberg N, Edwards M . Recommendations for Screening and Diagnosis of Chagas Disease in the United States. J Infect Dis. 2021; 225(9):1601-1610. PMC: 9071346. DOI: 10.1093/infdis/jiab513. View

Montgomery S, Parise M, Dotson E, Bialek S . What Do We Know About Chagas Disease in the United States?. Am J Trop Med Hyg. 2016; 95(6):1225-1227. PMC: 5154432. DOI: 10.4269/ajtmh.16-0213. View

Stimpert K, Montgomery S . Physician awareness of Chagas disease, USA. Emerg Infect Dis. 2010; 16(5):871-2. PMC: 2953998. DOI: 10.3201/eid1605.091440. View

Cucunuba Z, Nouvellet P, Conteh L, Vera M, Angulo V, Dib J . Modelling historical changes in the force-of-infection of Chagas disease to inform control and elimination programmes: application in Colombia. BMJ Glob Health. 2017; 2(3):e000345. PMC: 5680445. DOI: 10.1136/bmjgh-2017-000345. View

. Congenital transmission of Chagas disease - Virginia, 2010. MMWR Morb Mortal Wkly Rep. 2012; 61(26):477-9. View

Maguire J, Mott K, Lehman J, Hoff R, Muniz T, Guimaraes A . Relationship of electrocardiographic abnormalities and seropositivity to Trypanosoma cruzi within a rural community in northeast Brazil. Am Heart J. 1983; 105(2):287-94. DOI: 10.1016/0002-8703(83)90529-x. View

Castro-Sesquen Y, Saldana A, Patino Nava D, Bayangos T, Paulette Evans D, DeToy K . Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area. Clin Infect Dis. 2020; 72(9):e303-e310. PMC: 8096267. DOI: 10.1093/cid/ciaa1101. View

10.

. Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015; 90(6):33-43. View

11.

Berto C, Coyle C, Friedman L, Walker P . Where was my patient born? The Intersection of tropical medicine and migrant health. Curr Opin Infect Dis. 2021; 34(5):447-454. DOI: 10.1097/QCO.0000000000000773. View

12.

Meymandi S, Hernandez S, Forsyth C . A Community-Based Screening Program for Chagas Disease in the USA. Trends Parasitol. 2017; 33(11):828-831. DOI: 10.1016/j.pt.2017.07.003. View

13.

Kransdorf E, Zakowski P, Kobashigawa J . Chagas disease in solid organ and heart transplantation. Curr Opin Infect Dis. 2014; 27(5):418-24. DOI: 10.1097/QCO.0000000000000088. View

14.

Manne-Goehler J, Reich M, Wirtz V . Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015; 93(1):108-13. PMC: 4497880. DOI: 10.4269/ajtmh.14-0826. View

15.

Fabbro D, Danesi E, Olivera V, Codebo M, Denner S, Heredia C . Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis. 2014; 8(11):e3312. PMC: 4239005. DOI: 10.1371/journal.pntd.0003312. View

16.

Edwards M, Rench M, Todd C, Czaicki N, Steurer F, Bern C . Perinatal Screening for Chagas Disease in Southern Texas. J Pediatric Infect Dis Soc. 2015; 4(1):67-70. PMC: 10165846. DOI: 10.1093/jpids/pit056. View

17.

Alonso-Vega C, Billot C, Torrico F . Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009. PLoS Negl Trop Dis. 2013; 7(7):e2304. PMC: 3708826. DOI: 10.1371/journal.pntd.0002304. View

18.

de Andrade A, Zicker F, de Oliveira R, Almeida Silva S, Luquetti A, Travassos L . Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet. 1996; 348(9039):1407-13. DOI: 10.1016/s0140-6736(96)04128-1. View

19.

Montgomery S, Starr M, Cantey P, Edwards M, Meymandi S . Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hyg. 2014; 90(5):814-818. PMC: 4015570. DOI: 10.4269/ajtmh.13-0726. View

20.

Paz-Bailey G, Monroy C, Rodas A, Rosales R, Tabaru R, Davies C . Incidence of Trypanosoma cruzi infection in two Guatemalan communities. Trans R Soc Trop Med Hyg. 2002; 96(1):48-52. DOI: 10.1016/s0035-9203(02)90236-1. View